Suppr超能文献

[突变型p53研究进展]

[Advances on mutant p53 research].

作者信息

Li Da-Hu, Zhang Ling-Qiang, He Fu-Chu

机构信息

State Key Laboratory of Proteomics, Beijing Institute of Radiation Medicine, Beijing 100850, China.

出版信息

Yi Chuan. 2008 Jun;30(6):697-703. doi: 10.3724/sp.j.1005.2008.00697.

Abstract

Inactivation of tumor suppressor gene is a key event in carcinogenesis. p53 is one of the most important tumor suppressor genes in the genome, and its mutations are found in approximately 50% of human cancers. p53 mutation is also the main cause for human Li-Fraumeni syndrome. The vast majority of p53 mutations are missense mutations, and the corresponding mutant p53 proteins not only lose wild-type p53 tumor suppressor activities, but also gain new oncogenic properties favoring cancer development. Here, we mainly discussed the structural and functional alterations of mutant p53, the molecular mechanisms underlying gain of oncogenic functions, and the strategies and explorations of suppressing mutant p53 activities.

摘要

肿瘤抑制基因的失活是致癌过程中的关键事件。p53是基因组中最重要的肿瘤抑制基因之一,在大约50%的人类癌症中都发现有其突变。p53突变也是人类李-佛美尼综合征的主要病因。绝大多数p53突变是错义突变,相应的突变型p53蛋白不仅丧失野生型p53的肿瘤抑制活性,还获得了有利于癌症发展的新致癌特性。在此,我们主要讨论了突变型p53的结构和功能改变、致癌功能获得的分子机制,以及抑制突变型p53活性的策略和探索。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验